NCT07237594 2026-03-11
REPLAY
Duke University
Phase 1 Not yet recruiting
Clinical Trials
30 trialsNCT07442292 2026-03-05
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
Peking University Cancer Hospital & Institute
Not yet recruiting
NCT07444606 2026-03-03
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases
M.D. Anderson Cancer Center
Phase 1 Not yet recruiting
NCT07437300 2026-02-27
FIBIOME
University Hospital, Grenoble
Not yet recruiting
NCT07406087 2026-02-25
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Kaiser Permanente
Phase NA Not yet recruiting
NCT07405086 2026-02-12
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
OHSU Knight Cancer Institute
Phase 2 Not yet recruiting
NCT07389525 2026-02-05
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
Indiana University
Phase EARLY_PHASE1 Not yet recruiting
NCT07354152 2026-01-21
COPERGRAM1
Nantes University Hospital
Not yet recruiting
NCT07340619 2026-01-14
EPIBREAST
UNICANCER
Phase 2 Not yet recruiting
NCT07320222 2026-01-06
CARE-Melanoma
McMaster University
Phase 1 Not yet recruiting
NCT07102212 2025-12-24
FOCUS
Ohio State University Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT07293598 2025-12-19
ROTATE
The Christie NHS Foundation Trust
Not yet recruiting
NCT06897735 2025-11-18
EDDIS-a1
Petrov, Andrey
Phase 1 Not yet recruiting
NCT07114172 2025-08-11
Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers
Xijing Hospital
Phase NA Not yet recruiting
NCT07092410 2025-07-29
SuRage-EB
SRH Wald-Klinikum Gera GmbH
Phase 4 Not yet recruiting
NCT06756295 2025-03-12
FAST-CR
The University of Hong Kong-Shenzhen Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06785974 2025-01-22
SPIRAL
Erasmus Medical Center
Phase 4 Not yet recruiting
NCT06780397 2025-01-17
Mel-Immuno-Reu
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting
NCT06710093 2024-11-29
PerceIVe
Royal Marsden NHS Foundation Trust
Not yet recruiting
NCT06661577 2024-10-28
An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.
University of Auckland, New Zealand
Not yet recruiting
NCT06566404 2024-09-23
CORRESPOND
European Institute of Oncology
Not yet recruiting
NCT06553781 2024-08-14
A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma
Fudan University
Phase NA Not yet recruiting
NCT06414343 2024-06-25
LATENT
Royal Marsden NHS Foundation Trust
Not yet recruiting
NCT06470880 2024-06-24
DyNAMIc
The Christie NHS Foundation Trust
Phase 2 Not yet recruiting
NCT06424626 2024-05-22
A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma
Peking University Cancer Hospital & Institute
Phase 1 Not yet recruiting
NCT06327698 2024-03-25
Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
Hunan Cancer Hospital
Phase 2 Not yet recruiting
NCT06212388 2024-01-25
Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
Xijing Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT05539118 2022-09-14
Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma
Xijing Hospital
Phase 1/2 Not yet recruiting
NCT04477876 2020-07-20
NKCD160MEL
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
NCT02498756 2015-07-15
Cytokine-induced Killer Study for Patients With Stage II Melanoma
The First People's Hospital of Changzhou
Phase 2 Not yet recruiting